| Announce Date | 10/27/2025 |
| EPS Normalized Actual | $5.69 (Beat by $1.03) |
| EPS GAAP Actual | $5.69 (Beat by $1.03) |
| Revenue Actual | $4.49524B |
| Revenue Surprise | Beat by $4495.24M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $3.37904 |
| EPS GAAP Estimate | $3.37904 |
| Revenue Estimate | $4.079473698B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 27.06 | 8.47 | 26.50932 | 27.65985 | 2 |
| Dec 2028 | 24.81 | 9.24 | 24.30511 | 25.35998 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.8 | 2.1944 | 4.49524B | 11.84% | 431.05M |
| FQ2 2025 (Jun 2025) | 5.49 | 5.49 | 4.28382B | 8.78% | 4283.82M |
| FQ1 2025 (Mar 2025) | 4.87 | 4.87 | 4.09972B | 6.25% | 4099.72M |
| FQ4 2024 (Dec 2024) | -12.17 | -12.17 | 4.11372B | 9.97% | 4113.72M |
| FQ3 2024 (Sep 2024) | 3.89 | 3.89 | 3.96303B | 10.1% | 3963.03M |
| FQ2 2024 (Jun 2024) | 4.32 | 4.32 | 3.9076B | 9.2% | 3907.6M |
| FQ1 2024 (Mar 2024) | 3.9 | 3.9 | 3.84358B | 9.78% | 3843.58M |
| FQ4 2023 (Dec 2023) | 3.09 | 3.09 | 3.70355B | 100% | 3703.55M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
3.37904
Consensus Revenue Estimates
4.079473698B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.42931 | -- | 6.35318 | 6.47897 | 6 |
| FQ3 2027 (Sep 2027) | 5.49758 | -- | 5.39885 | 5.5923 | 3 |
| FQ2 2027 (Jun 2027) | 5.79139 | -- | 5.68739 | 5.89117 | 5 |
| FQ1 2027 (Mar 2027) | 4.91883 | -- | 4.8305 | 5.00358 | 3 |
| FQ4 2026 (Oct 2026) | 3.75811 | -- | 3.68542 | 3.80117 | 3 |
| FQ3 2026 (Jul 2026) | 4.02761 | -44.01 | 3.94971 | 4.07376 | 3 |
| FQ2 2026 (Jun 2026) | 3.98 | -37.94 | 3.86952 | 4.0723 | 3 |
| FQ1 2026 (Mar 2026) | 3.68 | -32.34 | 3.57784 | 3.76534 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.92B | -- | 4.88B | 4.95B | 7 |
| FQ3 2027 (Sep 2027) | 4.75B | -- | 4.69B | 4.82B | 4 |
| FQ2 2027 (Jun 2027) | 4.65B | -- | 4.59B | 4.72B | 6 |
| FQ1 2027 (Mar 2027) | 4.56B | -- | 4.5B | 4.62B | 4 |
| FQ4 2026 (Oct 2026) | 4.33B | -- | 4.27B | 4.37B | 4 |
| FQ3 2026 (Jul 2026) | 4.32B | -3.98 | 4.26B | 4.36B | 4 |
| FQ2 2026 (Jun 2026) | 4.33B | 1.13 | 4.24B | 4.41B | 4 |
| FQ1 2026 (Mar 2026) | 4.19B | 2.14 | 4.1B | 4.26B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.6056 | 5.8 | 2.1944 | 37.83% |
| FQ2 2025 (Jun 2025) | 5.49 | 5.49 | 100% | |
| FQ1 2025 (Mar 2025) | 4.87 | 4.87 | 100% | |
| FQ4 2024 (Dec 2024) | -12.17 | -12.17 | 100% | |
| FQ3 2024 (Sep 2024) | 3.89 | 3.89 | 100% | |
| FQ2 2024 (Jun 2024) | 4.32 | 4.32 | 100% | |
| FQ1 2024 (Mar 2024) | 3.9 | 3.9 | 100% | |
| FQ4 2023 (Dec 2023) | 3.09 | 3.09 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $4.06B | $4.5B | $431.05M | 9.59% |
| FQ2 2025 (Jun 2025) | $0B | $4.28B | $4283.82M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $4.1B | $4099.72M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $4.11B | $4113.72M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.96B | $3963.03M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.91B | $3907.6M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.84B | $3843.58M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.7B | $3703.55M | 100% |